Volume 23 - Issue 12 - December 2011

Predictive Value of SYNTAX Score in Risk Stratification of Patients Undergoing Unprotected Left Main Coronary Artery Angioplasty

João Brito, MD, Rui Teles, MD, Manuel Almeida, MD, Pedro de Araújo Gonçalves, MD, Luis Raposo, MD, Pedro Sousa, MD, Miguel Mendes, MD  

Abstract: Background. The SYNTAX score is a useful tool to evaluate percutaneous coronary intervention risk regarding the number, complexity, and location of lesions. Despite its proven value in the prognosis of three-vessel disease, there are few data about its usefulness in other selected subsets of patients. This study aimed to evaluate the prognostic value of the SYNTAX score in a population of patients who underwent unprotected left main coronary artery (ULMCA) angioplasty in our hospital....

Predictors of Clinical SYNTAX Score in Coronary Artery Disease: Serum Uric Acid, Smoking, and Framingham Risk Stratification

Zhaojun Xiong, MD1*, Cansheng Zhu, MD2*, Xiaoxian Qian, MD1, Jieming Zhu, MD1, Zhen Wu, MD1, Lin Chen, MD1

Abstract: Background. High serum uric acid (SUA) has been well demonstrated to be associated with morbidity and mortality in the general population as well as in patients with coronary artery disease (CAD). Recent studies show that the clinical SYNTAX score (CSS) is a new tool for the risk stratification of patients with complex CAD. In this study, we aimed to evaluate whether SUA was associated with the complexity of CAD as evaluated by the CSS....

The SYNTAX Score Predicts Early Mortality Risk in the Elderly with Acute Coronary Syndrome Having Primary PCI

Frank Scherff, MD1*, Giuseppe Vassalli, MD1,2*, Daniel Sürder, MD1, Antonio Mantovani, MD1, Carlo Corbacelli, MD1, Elena Pasotti, MD1, Catherine Klersy, MD, MSc3, Angelo Auricchio, MD, PhD1, Tiziano Moccetti, MD1, Giovanni B. Pedrazzini, MD1

Abstract: Background. The SYNTAX score (SXscore), an angiographic score reflecting coronary lesion complexity, predicts clinical outcomes in patients with left main or multivessel disease, and in patients with ST-segment elevation myocardial infarction undergoing primary PCI. The clinical SXscore (CSS) integrates the SXscore and clinical variables (age, ejection fraction, serum creatinine) into a single score....

The SYNTAX Score: Usefulness, Limitations, and Future Directions

Anjan K. Chakrabarti, MD and C. Michael Gibson, MS, MD

In 2009, the landmark Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial sought to establish whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) was the standard of care for patients with three-vessel or left main coronary artery disease.1...

Percutaneous Closure of the Patent Ductus Arteriosus Using the Nit-Occlud PDA-R (Reverse) Device: Initial Experience Reporting Immediate and Short-Term Results

Alejandro Peirone, MD, Juan Diaz, MD, Alejandro Contreras, MD, Edgardo Banille, MD, Marcelo Cabrera, MD, Ana Spillmann, MD, Nora Bueno, MD, Ernesto Juaneda, MD

Abstract: Purpose. To review the initial clinical outcomes of patent ductus arteriosus (PDA) closure using the new Nit-Occlud PDA-R device (NOPDA-R). Materials and methods. The NOPDA-R is a self-expandable, nitinol-made, premounted and cone-shaped device with two distinctive features: reverse reconfiguration of the distal disc and a peculiar “snare-like” release mechanism. From May to December 2010, 20 consecutive patients were included....

Percutaneous Closure of Patent Ductus Arteriosus — Current Status

P. Syamasundar Rao, MD

Since the description of successful surgical ligation of patent ductus arteriosus (PDA) by Gross and Hubbard in 1939,1 surgery has been the procedure of choice in the treatment of PDA. Surgical treatment has been shown to be safe and effective with only occasional complications. However, investigators have been attempting to develop less invasive, transcatheter methods to occlude the PDA....

30-Day Outcome After Percutaneous Coronary Angioplasty in Nonagenarians: Feasibility and Specific Considerations in Different Clinical Settings

Alberto Hendler, MD, Mark Katz, MD, Yoseph Gurevich, MD, Meir Reicher, MD, Alex Blatt, MD, Zyad Gabara, MD, Itzhak Zyssman, MD, Zvi Vered, MD, Ricardo Krakover, MD

Abstract: Background. Nonagenarians have been systematically excluded from randomized trials dealing with invasive coronary strategies, resulting in a lack of evidence-based guidelines regarding the optimal approach in this population. Aim. To describe the clinical and procedural characteristics and outcomes of patients 90 years of age or older who were treated with percutaneous coronary interventions (PCI)....

Percutaneous Coronary Intervention in the Very Elderly: Do Nonagenarians Have the Most to Gain or the Most to Lose?

Dean Ferrera, DO and Adhir Shroff, MD, MPH

The elderly are often poorly represented in major clinical trials of percutaneous coronary intervention (PCI).1 An exact definition for “elderly” varies; for instance, the 2002 ACC/AHA practice guideline for the management of acute coronary syndromes considered patients ≥75 as a special “at-risk” group.2 Many clinical trials exclude patients over 75. ...

Radial Artery Spasm During Transradial Coronary Procedures

Ivica Kristic, MD and Josip Lukenda, MD, PhD

Abstract: Although transradial access (TRA) for coronary procedures has many advantages over the transfemoral approach, it’s still not the dominant route used in coronary interventions. Radial artery spasm (RAS) is an important limitation of TRA. We performed a search of published literature to estimate the prevalence and possible risk factors of RAS in patients undergoing transradial coronary procedure....

Early Detection of Chronic Myocardial Ischemia in a Patient Implanted with an ICD Capable of Intracardiac Electrogram Monitoring

Lida P. Papavasileiou, MD, PhD, Giovanni B. Forleo, MD, PhD, Francesco Romeo, MD

Abstract: Although myocardial ischemia monitored by some implantable cardioverter-defibrillators has the potential to improve patient care, no clinical experience with this novel technology has been described yet. We report for the first time ischemic intracardiac ST changes detected in a patient with coronary artery disease.

J INVASIVE CARDIOL 2011;23(12):532-533...

Editorial Staff
  • Executive Officer
    Laurie Gustafson
  • Production
    Elizabeth Vasil
  • National Account Manager
    Jeff Benson
  • Senior Account Director
    Carson McGarrity
  • Special Projects Editor
    Amanda Wright
Editorial Correspondence
  • Laurie Gustafson, Executive Editor, JIC
  • HMP Communications, 83 General Warren Blvd

    Suite 100, Malvern PA 19355
  • Telephone: (248)360-2777 or

    (610)560-0500, ext. 121

    Fax: (610)560-0501.
  • E-mail: lgustafson@hmpcommunications.com

Back to top